Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linerixibat in PBC with Pruritus
NCT01899703Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linerixibat in primary biliary cholangitis (PBC), pruritus, sponsored by GSK. Started Mar 2014; status: completed.
02
Drugs
linerixibat
03
Conditions
primary biliary cholangitis (PBC)pruritus
Beyond the preview
Go deeper on NCT01899703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01899703.